SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001165527-10-000227
Filing Date
2010-03-19
Accepted
2010-03-19 16:57:16
Documents
7
Period of Report
2010-03-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT DATED 3-15-10 g3967.txt 8-K 90643
2 CERTIFICATE OF CHANGE ex3-12.txt EX-3.1.2 2776
3 ARTICLES OF MERGER ex3-13.txt EX-3.1.3 16253
4 AGREEMENT AND PLAN OF MERGER ex10-1.txt EX-10.1 6421
5 ASSET PURCHASE AGREEMENT ex10-2.txt EX-10.2 49416
6 PATENT AND KNOW HOW LICENSE ex10-3.txt EX-10.3 84326
7 FORM OF SUBSCRIPTION AGREEMENT ex10-4.txt EX-10.4 14923
  Complete submission text file 0001165527-10-000227.txt   266859
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53127 | Film No.: 10694723
SIC: 4731 Arrangement of Transportation of Freight & Cargo